Home › Vetr Inc. Upgrades Vertex Pharmaceuticals to Buy
 

Keywords :   


Vetr Inc. Upgrades Vertex Pharmaceuticals to Buy

2015-11-30 03:30:58| Biotech - Topix.net

The firm currently has a $137.08 price objective on the pharmaceutical company's stock. Vetr 's price objective would indicate a potential upside of 3.02% from the stock's previous close.

Tags: buy upgrades pharmaceuticals vertex

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09This weeks lesson: Weaning matters in the cattle market
More »